Home2AB • FRA
add
Barinthus Biotherapeutics PLC - ADR
Nakaraang pagsara
€0.90
Sakop ng araw
€0.82 - €0.82
Sakop ng taon
€0.76 - €3.24
Market cap
35.93M USD
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 14.97M | — |
Gastos sa pagpapatakbo | 23.72M | 49.31% |
Net na kita | -8.11M | 42.34% |
Net profit margin | -54.21 | — |
Kita sa bawat share | -0.21 | 43.24% |
EBITDA | -8.48M | 41.43% |
Aktuwal na % ng binabayarang buwis | 0.04% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 106.10M | -33.81% |
Kabuuang asset | 188.69M | -17.95% |
Kabuuang sagutin | 29.23M | -14.95% |
Kabuuang equity | 159.46M | — |
Natitirang share | 40.23M | — |
Presyo para makapag-book | 0.22 | — |
Return on assets | -12.19% | — |
Return on capital | -13.40% | — |
Cash Flow
Net change in cash
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -8.11M | 42.34% |
Cash mula sa mga operasyon | -18.20M | -62.61% |
Cash mula sa pag-invest | -114.00K | -216.67% |
Cash mula sa financing | 465.00K | 910.87% |
Net change in cash | -11.67M | 8.25% |
Malayang cash flow | -18.26M | -1,948.34% |
Tungkol
Barinthus Biotherapeutics plc is a biotechnology company developing immunotherapies for infectious diseases, cancer and autoimmune diseases such as hepatitis B, HPV and prostate cancer. Formerly known as Vaccitech plc, in November 2023 the company announced that it had renamed itself to Barinthus Biotherapeutics plc. As of 2024, the company employs more than 100 people. Wikipedia
Itinatag
2016
Website
Mga Empleyado
130
